Pfizer's new vaccine R&D leader Anderson has a high bar to reach in replacing Jansen

As Pfizer’s new VP and head of the company’s vaccine research and development, Annaliesa Anderson, Ph.D., has a tough act to follow.

Related Keywords

,Pfizer ,Kathrin Jansen ,Covid 19 ,Pneumococcal Vaccine ,Iontech ,Prevnar ,Gardasil ,Fierce Pharma Homepage ,Pharma ,